Corpus Intelligence IC Memo — BIG SOUTH FORK MEDICAL CENTER 2026-04-26 15:42 UTC
IC Memo — BIG SOUTH FORK MEDICAL CENTER
Investment Committee Memorandum | TN | 25 beds | Grade C | EBITDA uplift $989K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

BIG SOUTH FORK MEDICAL CENTER

CCN 441323 | SCOTT, TN | 25 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

BIG SOUTH FORK MEDICAL CENTER is a 25-bed suburban community hospital in SCOTT, TN with $13.4M in net patient revenue and a 11.2% operating margin. The hospital serves a payer mix of 36.6% Medicare, 16.3% Medicaid, and 47.1% commercial.

Thesis: Turnaround. Our ML models identify $989K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 11.2% to 18.6% (+737bps).

Net Revenue HCRIS$13.4M
Current EBITDA COMPUTED$1.5M
Operating Margin COMPUTED11.2%
Occupancy HCRIS10.3%
Revenue / Bed COMPUTED$537K
Net-to-Gross HCRIS25.8%
Distress Probability ML60.9%

2. Market Context & Competitive Position

141
TN Hospitals
-0.6%
State Median Margin
55
Comparable Hospitals

TN has 141 Medicare-certified hospitals with a median operating margin of -0.6%. The target's margin of 11.2% places it above the state median. Among 55 size-comparable peers (12-50 beds), the median margin is -0.8%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-50), prioritizing same-state peers. 55 hospitals in the comp set.

HospitalStateBedsRevenueMargin
BIG SOUTH FORK MEDICAL CENTER (Target)TN25$13.4M11.2%
BAPTIST MEM HOSPITAL TIPTON COTN48$179.0M-5.8%
INDIAN PATH COMMUNITY HOSPITALTN35$142.8M12.0%
HENRY COUNTY MEDICAL CENTERTN43$81.7M-13.0%
THE CENTER FOR SPINAL SURGERYTN23$78.7M39.3%
TRUSTPOINT HOSPITALTN18$50.8M-0.8%
BAPTIST MEM HOSPITAL UNION CITTN43$50.5M5.1%
VANDERBILT BEDFORD COUNTY HOSPTN24$49.5M1.9%
NEWPORT MEDICAL CENTERTN32$47.8M11.6%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $989K (737bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$282K+210bp18mo
Cost to Collect4.5%2.5%$268K+200bp12mo
Denial Rate Reduction12.0%6.5%$267K+199bp12mo
A/R Days Reduction5200.0%3800.0%$163K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+7bp6mo

5. EBITDA Bridge

Net Collection Rate
$282K
Cost to Collect
$268K
Denial Rate Reduction
$267K
A/R Days Reduction
$163K
Clean Claim Rate
$10K
Total EBITDA Uplift$989K
Current EBITDA$1.5M
+ RCM Uplift+$989K
Pro Forma EBITDA$2.5M
Current Margin11.2%
Pro Forma Margin18.6%
WC Released (1x)$515K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$2.3M$19.8M8.56x53.6%
Base (11x exit)10.0x11.0x$2.3M$22.6M9.74x57.7%
Bull Case9.0x11.0x$2.1M$26.6M12.75x66.4%
Bull (12x exit)9.0x12.0x$2.1M$29.6M14.21x70.0%
Bear Case11.0x10.0x$2.5M$14.1M5.54x40.9%
Bear (11x exit)11.0x11.0x$2.5M$16.4M6.42x45.1%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumLow occupancyAt 10.3%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 60.9% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 55 hospitals with 12-50 beds
  • Same-state prioritization (n=56)
  • Comp margins: P25=-14.4% / P50=-0.8% / P75=8.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.